Gene Biotherapeutics CRXM Stock
Gene Biotherapeutics Price Chart
Gene Biotherapeutics CRXM Financial and Trading Overview
Gene Biotherapeutics stock price | 0.0001 USD |
Previous Close | 1.0E-6 USD |
Open | 1.0E-6 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 1.0E-6 - 1.0E-6 USD |
52 Week Range | 1.0E-6 - 0.0001 USD |
Volume | 58 USD |
Avg. Volume | 0 USD |
Market Cap | 64 USD |
Beta (5Y Monthly) | -19.65669 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CRXM Valuation Measures
Enterprise Value | 181.52K USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -0.144 |
Trading Information
Gene Biotherapeutics Stock Price History
Beta (5Y Monthly) | -19.65669 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0001 USD |
52 Week Low | 1.0E-6 USD |
50-Day Moving Average | 0.0001 USD |
200-Day Moving Average | 0.0001 USD |
CRXM Share Statistics
Avg. Volume (3 month) | 0 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 64.93M |
Float | 60.79M |
Short Ratio | 1.03 |
% Held by Insiders | 6.37% |
% Held by Institutions | 0% |
Shares Short | 150.25K |
Short % of Float | 1.78% |
Short % of Shares Outstanding | 1.70% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2020 |
Most Recent Quarter (mrq) | December 31, 2020 |
Next Fiscal Year End | December 31, 2021 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -261.90% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -1260365 USD |
Net Income Avi to Common (ttm) | -517897 USD |
Diluted EPS (ttm) | -0.02 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 386.03K USD |
Total Cash Per Share (mrq) | 0.006 USD |
Total Debt (mrq) | 1.26M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.082 |
Book Value Per Share (mrq) | -0.096 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1133005 USD |
Levered Free Cash Flow (ttm) | -707668 USD |
Profile of Gene Biotherapeutics
Country | United States |
State | CA |
City | San Diego |
Address | 11230 Sorrento Valley Road |
ZIP | 92121 |
Phone | 858 414 1477 |
Website | https://genebiotherapeutics.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 3 |
Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. It is also developing Generx for ischemia-related cardiovascular and cerebral therapeutic indications. Gene Biotherapeutics, Inc. has an agreement with Fujifilm Diosynth Biotechnologies for the manufacture of Generx angiogenic gene therapy product for Phase 3 clinical evaluation. The company was formerly known as Taxus Cardium Pharmaceuticals Group, Inc. and changed its name to Gene Biotherapeutics, Inc. in January 2018. Gene Biotherapeutics, Inc. was incorporated in 2003 and is headquartered in San Diego, California.
Q&A For Gene Biotherapeutics Stock
What is a current CRXM stock price?
Gene Biotherapeutics CRXM stock price today per share is 0.0001 USD.
How to purchase Gene Biotherapeutics stock?
You can buy CRXM shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gene Biotherapeutics?
The stock symbol or ticker of Gene Biotherapeutics is CRXM.
Which industry does the Gene Biotherapeutics company belong to?
The Gene Biotherapeutics industry is Biotechnology.
How many shares does Gene Biotherapeutics have in circulation?
The max supply of Gene Biotherapeutics shares is 64.93M.
What is Gene Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Gene Biotherapeutics PE Ratio is 0.00000000 now.
What was Gene Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Gene Biotherapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Gene Biotherapeutics company belong to?
The Gene Biotherapeutics sector is Healthcare.